Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
29.43
+0.50 (1.73%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Maze Therapeutics Market Cap
Maze Therapeutics has a market cap or net worth of $1.63 billion as of August 24, 2026. Its market cap has increased by 176.57% in one year.
Market Cap
1.63B
Enterprise Value
1.20B
1-Year Change
176.57%
Ranking
Category
Stock Price
$29.43
ChartMarket Cap Chart
Since the IPO on January 31, 2025, Maze Therapeutics's market cap has increased from $685.23M to $1.63B, an increase of 138.58%. That is a compound annual growth rate of 75.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 1.63B | -18.00% |
| Dec 31, 2025 | 1.99B | 190.94% |
| Jan 31, 2025 | 685.23M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 1.75B |
| AnaptysBio | 1.71B |
| Avalyn Pharma | 1.70B |
| Vir Biotechnology | 1.65B |
| Absci | 1.64B |
| Bicara Therapeutics | 1.58B |
| Tyra Biosciences | 1.55B |
| Apnimed | 1.55B |